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This article examines ﬁnancing in the ﬁght against malaria. After brieﬂy describing malaria
control plans in Africa since 2000, it offers a stylized model of the economics of malaria and
shows how health aid can help escape the malaria trap.
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It is more than a decade since the report from the Committeeon the Economics of Antimalarial Drugs, led by NobelLaureate Kenneth Arrow was published1. Several studies have
since shown that worldwide malaria deaths declined dramatically
between 2000 and 20142. This massive reduction in malaria-
related mortality may have effects that reach beyond health.
Improving early childhood health paves the way for greater
human capital accumulation, changed fertility patterns, and
faster economic development. A decline in malaria can thus
generate a wide range of outcomes, many of them positive.
However, interventions across the varied epidemiological
settings of Africa remain poorly understood. Two inﬂuential
articles have been recently published to improve our
understanding3,4. To assess the change in malaria prevalence
from 2000 to 2015 and to quantify the effects of malaria con-
trol, these articles use a large consolidated database from
ﬁeld surveys and combine this database with program data
to ﬁght against malaria. They ﬁnd that the prevalence of
Plasmodium falciparum infections in Africa decreases by half
between 2000 and 2015. Malaria mortality rates also fell by
57% during the period. These studies interpret these results
as the effect of malaria control programs and consider that
among control measures, insecticide-treated nets were the
most effective. They alone contribute to 68% of the progress
made. These two studies provide the best estimates to date.
However, according to the 2018 World Malaria Report, the
estimated number of malaria cases worldwide was 219 million in
2017 (216 million in 2016). Data for 2015−2017 show no sig-
niﬁcant progress towards reducing the number of malaria cases
worldwide and the malaria mortality reduction rate has also
slowed (435,000 deaths in 2017)5. While these data and their
quality are to be considered with caution, this stunt in the ﬁght
against malaria is attributed in part by the World Health Orga-
nization (WHO) to insufﬁcient investments to achieve the
objectives of the Global Technical Strategy for malaria 2016
−2030 (GTS), namely to reduce by at least 40% malaria-speciﬁc
mortality compared to 2015. Investment stagnates indeed since
2010 while the needs remain considerable and many researchers
have sent out alarm signals6,7.
This article examines ﬁnancing in the ﬁght against malaria.
After brieﬂy describing malaria control plans in Africa since 2000,
it offers a stylized model of the economics of malaria and shows
how foreign health aid might help escape the disease trap.
Results
A stylized model of malaria and health aid. We focus on the
basic reproductive number under control (PfRc), within the
limits of stable Plasmodium falciparum transmission, which
provides the potential for the disease to spread within a naive
population moderated by malaria control. The estimates of PfRc
were generated by the Malaria Atlas Project using a malaria
transmission model to describe the relationship between PfRc
and the predicted probability distribution of parasite prevalence.
Figure 1 shows the average PfRc, using data from the Malaria
Atlas project including 42 African countries from 2000 to 2016.
Though the estimates of PfRc encapsulate uncertainty in both
the underlying prevalence estimates and in the parameterization
of the malaria transmission model, it is probably the best estimate
at hand3.
To understand the effects of malaria aid on the basic
reproductive number under control, we start from Berthélemy
and Thuilliez, who consider R0 as a natural reproductive
number and add individual protective decisions through a
utility maximization program8. As usual, if R0Natural is lower
than 1, the disease converges toward elimination, which is far
from the case today (Fig. 1, green line), even when taking
control programs into account. From an economic perspective,
PfRc can be considered as the result of the natural basic
reproductive number multiplied by the proportion of unpro-
tected population:
PfRc ¼ R0Naturalð1 HÞ; ð1Þ
where H is the aggregate protection in the population that could
be thought as the use of LLINs.
The fast reduction of PfRc observed from 2000 to 2015 can be
primarily considered as the positive result of Roll Back Malaria
campaigns using protection tools such as LLINs—that is, an
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Fig. 1 PfRc (geometric mean from the Malaria Atlas Project-MAP) and predicted PfRc (geometric mean from authors' predictions). The ﬁgure provides a
static simulation of the model, as a simpliﬁed prediction of PfRc compared to the true values of PfRc provided by the Malaria Atlas Project. The blue line
provides estimates from a standard ﬁxed-effects model (within country). The orange line provides estimates from the Arellano−Bond model. The green
line provides the Malaria Atlas Project PfRc
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increase in H. Before the campaign, protection was relatively
scarce. From an economic point of view, consider gradual
increases in H as the result of adopting innovation. In economic
analyses, such processes of adoption follow an ordinary logistic
function, which is of course S-shaped. As a result, we model the
dynamics of H as follows:
dH
dt
¼ H½α βH; α  β: ð2Þ
In the long run, H converges to α=β. Note that in an equality, H
tends to 1 and PfRc tends to 0. As a result, the rate of growth of
PfRc is a nonlinear function of PfRc.
dPfRc
dt
¼ PfRc R0Natural
α β
PfRc
 
þ β
R0Natural
PfRcþ α 2β
 
:
ð3Þ
The derivative of the growth rate of PfRc is:
R0Natural αβð Þ
PfRc2
þ βR0Natural. It follows that for low values of H (PfRc
close to R0Natural, H close to 0), dH > 0 and dPfRc < 0.
Symmetrically, for large values of H (R0Natural close to 0, H close
to 1), dH ≤ 0 and dPfRc ≥ 0.
Put differently, solving Eq. (3) at time independent equilibrium
yields the solution of either PfRc ¼ R0Natural (which is unstable for
α > 0) and PfRc ¼ R0Natural 1 αβ
 
, which is stable for α > 0 and
α< 1 (the condition for elimination) when R0Natural 1 αβ
 
< 1.
Thus, a poverty trap exists when R0Natural 1 αβ
 
 1.
This result is important because it shows that with the current
strategy and even with a scale-up of LLINs, eliminating malaria
is improbable because, for high protection coverage (large
values of H), PfRc will tend to increase. The persistence of
such a health trap, associated with R0Natural 1 αβ
 
> 1—with a
long run PfRc higher than 1—suggests that without intervention
(through aid), it will be impossible to get out of the trap, unless
very large amounts of aid are invested, assuming that aid
increases adoption and coverage of LLINs—although use of
interventions is less well understood—and then increases α.
The argument is not that only a big push could solve this
situation, but that reducing the cost of adoption of innovations
by households through aid interventions may contribute to
increase LLINs’ coverage—possession and use—and reduce the
long-run PfRc. There are certainly other demand-side barriers
and opportunity costs associated with LLINs usage that may
constrain the scale-up of LLINs’ coverage. Reducing malaria
aid would thus be catastrophic as supported by dynamic
modeling papers where a “reverse” or counterfactual scenario
is explored9.
Illustration. To illustrate how health aid may alleviate this issue
partially, we use the panel of 42 sub-Saharan African countries to
estimate the following growth model of PfRc and check whether
malaria aid may enable escaping such a trap:
ln PfRcð ÞCountry;t ¼ δ þ θ1 ln PfRcð ÞCountry;t1þ θ2 ln PfRcð Þ2Country;t1
þ θ3Malaria AidCountry;t þ θ4GDP per capitaCountry;t þ εCountry;t
:
ð4Þ
Equation (4) is a discretization of the continuous equation
given by Eq. (3). Malaria aid data are from WHO–World Malaria
Reports and include disbursements from the Global Fund,
the World Bank Booster Program, the U.S. President’s Malaria
Initiative, and the UK-Aid Department for International Devel-
opment (DFID). GDP per capita is from WDI and PfRc is
from the Malaria Atlas Project. GDP per capita proxies poverty
incidence (not available on an annual basis), which can reduce
the adoption of protection innovations due to poverty trap
mechanisms10,11. We measure dPfRc/PfRc.dt as a logarithmic
growth rate, estimated as a quadratic function of ln(PfRc).
In an extended version of Eq. (4), we add public expenditure
on health from domestic sources per capita expressed in
international dollars at purchasing power parity (in PPP;
World Development Indicators). We next estimate the equation
using a standard ﬁxed-effects model (within country) or an
Arellano−Bond model (which helps reduce the endogeneity bias
inherent in dynamic ﬁxed-effect estimations).
Results from these stylized models are provided in Table 1.
Figure 1 provides a static simulation of the model, as a
simpliﬁed prediction of PfRc compared to the true values of
PfRc provided by the Malaria Atlas Project. Table 1 shows that
the predictions of the model are conﬁrmed. The effect of the
lagged values of Ln(PfRc) are positive. Predictions also perform
well and show that the level of PfRc is far above 1 in all cases.
Malaria aid has a signiﬁcant negative effect on PfRc in Africa,
an argument in favor of sustained development assistance,
but current levels of malaria aid will not be enough. Dynamic
Table 1 Results from ﬁxed-effects and Arellano−Bond estimates of Eq. (4)
Dependent var. is Ln(PfRc) Fixed-effects
model
Arellano
−Bond
Fixed-effects
model
Arellano−Bond
Lag. Ln(PfRc) 0.817***
(0.046)
0.580***
(0.038)
0.814***
(0.050)
0.561***
(0.041)
Squared Lag. Ln(PfRc) 0.035**
(0.016)
0.065***
(0.014)
0.036**
(0.018)
0.068***
(0.015)
Malaria aid per capita −0.002*
(0.002)
−0.011***
(0.002)
−0.003*
(0.002)
−0.010***
(0.002)
GDP per capita −9.84e-06***
(0.000)
−2.74e-05***
(0.000)
−1.02e-05***
(0.000)
−2.83e-05***
(0.000)
Domestic general government
health expenditure per capita
. . 1.66e-05
(0.000)
−6.66e-04***
(0.000)
Intercept 0.122***
(0.025)
0.335***
(0.022)
0.127***
(0.030)
0.404***
(0.027)
Observations 645 602 575 534
Countries 42 42 40 40
Years 2000−2016 2001−2016 2000−2016 2001−2016
*, ** and *** denote statistical signiﬁcance at the 10, 5 and 1% level, respectively
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extensions and simulations from our stylized model suggest
that a level of aid of US$25−US$30 per capita would be needed
to reach a PfRc of 1. This result is in accordance with other
estimations made in Africa12, where ﬁgures of up to US$20 were
estimated for elimination to be possible with current interven-
tions. It has been estimated that in the Asia-Paciﬁc, where malaria
incidence is lower, levels of around US$6−US$9 would be
required for elimination13. Importantly, the fact that aid has a
greater impact than local public health expenditures is an
indication of the weakness of national systems—the expenditure
ﬁnanced by aid being certainly better controlled and administered
and therefore more effective.
Figure 1 suggests a prevention adoption behavior that is
S-shaped and has helped reduce PfRc from about 3 initially to
about 2 in the long run, which would suggest a long run H of
about 33% on average at current levels of aid and GDP per capita.
This relatively low potential adoption may be partly explained
by a poverty and malaria trap mechanisms8,14,15, in which
individuals in a poverty trap would not adopt LLINs even if they
are fully subsidized. In recent years the poverty incidence
(at $1.90 a day) has on average been as high as 43% in sub-
Saharan Africa (according to the data provided by the World
Bank Povcalnet website).
Discussion
Of course, the malaria community acknowledges that current
level of international funding will not be sufﬁcient to eliminate
malaria. However, existing predictions do not illustrate the
possibility and the danger of a disease trap. Moreover, the
advocacy on malaria aid has not been supported by the com-
munity of economists since Sachs et al. or Arrow1,10,11.
Our model provides a renewed analysis on malaria aid. It also
uses foundations that are anchored in microeconomics to
illustrate the conditions of existence of a potential malaria trap.
We note that even with health aid, it is unlikely that malaria
will be successfully eliminated, which might generate a negative
incentive for international funders to invest in malaria control
programs. This is due to several factors including the arsenal
of currently available tools that may not be sufﬁcient to
control malaria to low levels of transmission, sustainability
of international funding as countries develop and become
wealthier, the role of public ﬁnancing, malaria epidemiological
speciﬁcities, among others. Moreover, combinations of tools
(including LLINs, insecticides spraying, Intermittent Preventive
Treatments and Artemisinin Combination Therapies) are
necessary to control malaria. Our model could apply to all of
these measures. However, LLINs have crystalized the debate
in the economic literature and we believe our stylized model
is easier to understand with LLINs alone. The unprotected
population could also beneﬁt from positive externalities through
those who are protected, as demonstrated for other infectious
diseases16. This should increase the effectiveness of both
malaria aid and malaria control and reinforce our conclusions,
as demonstrated elsewhere8.
To conclude, the poverty–disease-trap mechanisms may help
explain a large part of the problem. New international funding
sources or innovative ﬁnancing are unlikely in a near future.
Poverty reduction and universal strategies would thus be a natural
complement of health aid to help eliminate diseases like malaria.
In light of the global economy’s fragile recovery, African coun-
tries will need to reset their relationships with international aid
agencies and bilateral partners and possibly look more to
South–South cooperation and private–public partnerships.
Greater coordination of current aid players is therefore
needed so that available resources could have higher health
impact.
Data availability
All data used for this analysis are freely accessible at Malaria Atlas Project for the
PfRc (https://map.ox.ac.uk/), World Development Indicators (https://datacatalog.
worldbank.org/dataset/world-development-indicators), and WHO for malaria aid
(https://www.who.int/malaria/data/en/). All data were accessed on March 2018. The do
ﬁle and database used for the analysis are available upon request.
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